A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
Clinical trial NCT03128593 · COMPLETED
Trial details
- NCT number
- NCT03128593
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2017-10-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.